NHS Logo

Palliative radiotherapy for Merkel cell carcinoma: single-centre experience and review of the literature (Record no. 76292)

MARC details
000 -LEADER
fixed length control field 02766cam a2200193 4500
001 - CONTROL NUMBER
control field NMDX7368
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120401t2016 xxu||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Kanagaratnam, B.
240 ## - UNIFORM TITLE
Uniform title <a href="Journal of Radiotherapy in Practice">Journal of Radiotherapy in Practice</a>
245 ## - TITLE STATEMENT
Title Palliative radiotherapy for Merkel cell carcinoma: single-centre experience and review of the literature
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2016
500 ## - GENERAL NOTE
General note NMUH Staff Publications
500 ## - GENERAL NOTE
General note 15
520 ## - SUMMARY, ETC.
Summary, etc. &lt;p&gt;&lt;span style="font-size: 10pt;"&gt;Merkel cell carcinoma is a rare and aggressive primary cutaneous neuroendocrine carcinoma with a high risk of loco-regional and distant metastasis. It is predominantly seen in the elderly, on the head and neck or extremities. Although treated primarily with surgery, some patients are too frail. A World Health Organization performance status of two or more with co-existing medical co-morbidities, or the site of the disease adjacent to a critical structure, can prevent surgical management. In this cohort of patients, primary palliative radiotherapy has been found to achieve excellent tumour regression and improve quality of life. A new palliative split-course hypofractionated regime has been used in North Middlesex University Hospital in this cohort of patients. The purpose of this case series was to provide supporting evidence on the efficacy of this dose and fractionation regime and review the literature for the palliative management of Merkel cell carcinoma.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size: 10pt;"&gt;In total, four patients were treated with the palliative split-course hypofractionated regime. The regime consisted of an initial 20 Gray in 5 fractions over 1 week, a 2-week gap and then a further 20 Gray in 5 fractions over 1 week. Tolerability and response to treatment were evaluated by history and clinical examination.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size: 10pt;"&gt;The split-course hypofractionated regime was well tolerated, achieved excellent tumour regression and improved quality of life in all four patients. Since then, a further three patients have been successfully treated with the above regime. This case series demonstrates the efficacy of this dose and fractionation in a select group of patients too frail for radical management and adds to the evidence base for the optimal palliative management of Merkel cell carcinoma.&lt;/span&gt;&lt;/p&gt;
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Shah, A.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Anand, G.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1017/S1460396915000540">https://doi.org/10.1017/S1460396915000540</a>
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/7C436B17FBE2536EAC155D5DF14A0947/S1460396915000540a.pdf/palliative_radiotherapy_for_merkel_cell_carcinoma_singlecentre_experience_and_review_of_the_literature.pdf">https://www.cambridge.org/core/services/aop-cambridge-core/content/view/7C436B17FBE2536EAC155D5DF14A0947/S1460396915000540a.pdf/palliative_radiotherapy_for_merkel_cell_carcinoma_singlecentre_experience_and_review_of_the_literature.pdf</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Staff publications for NMDX Ferriman Information and Library Service (North Middlesex) Ferriman Information and Library Service (North Middlesex) Online 07/06/2022   07/06/2022 07/06/2022 UNKNOWN